-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 17, 2022, the Chinese Academy of Medical Sciences released "China's Important Medical Achievements in the 21st Century" and "China's Important Medical Progress in 2021" at the China Medical Development Conference
Figure 1 FAVOR III China, a large-scale RCT study on QFR technology developed by Tu Shengxian's research group, was selected as "China's Important Medical Progress in 2021" by the Chinese Academy of Medical Sciences
The FAVOR III China study was jointly led by Professor Xu Bo and Professor Qiao Shubin from Fuwai Hospital, Chinese Academy of Medical Sciences, and was jointly completed by Fuwai Hospital, School of Biomedical Engineering, Shanghai Jiaotong University and other units
The QFR technology was developed by Professor Tu Shengxian, a team of Academician Chen Yazhu of Shanghai Jiaotong University.
Related Links:
1.
2.
3.
Sun Qiong
School of Biomedical Engineering
